Gapping up
In reaction to earnings/guidance:
- DDS +11.9%, VAL +8.8%, NEX +8.6%, M +6.6%, TRU +5.9%, ICLR +3.6%, SNN +3.3%, ESPR +2.9%, WMB +2.4%, DNUT +1.9%, APA +1.8%, HL +1.6%, CNP +1.5%, LPX +1.3%
Select oil/gas related names showing strength:
- MRO +4.9%, OIH +3.5%, USO +2.9%, SLB +2.6%, HAL +2.6%, XLE +2%, XOM +1.9%, PSX +1.4%
Other news:
- DWAC +19.6% (Former President Trump's Truth Social application is now available)
- OCGN +17.3% (FDA lifts clinical hold on submission of IND application for COVAXIN)
- HMHC +15% (to be acquired by Veritas Capital for $21.00 per share in cash)
- TGNA +7.5% (confirms it will be acquired by Standard General for $24/share in cash)
- LTRY +5% (signed an agreement with T-Mobile to become the exclusive digital lottery brand for in-vehicle advertising)
- AZN +3.5% (reports ENHERTU (fam-trastuzumab deruxtecan-nxki) significantly improved both progression-free and overall survival in DESTINY-Breast04 Trial in Patients with HER2-Low Metastatic Breast Cancer)
- PRVB +1.5% (resubmits BLA for Teplizumab to Address Complete Response Letter)
- TCMD +0.9% (announces dismissal of qui tam lawsuit filed by competitor)
Analyst comments:
- CHX +2.3% (upgraded to Neutral from Sell at Goldman)
- PRVA +1% (upgraded to Outperform from Market Perform at Cowen)